Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04428515|
Recruitment Status : Recruiting
First Posted : June 11, 2020
Last Update Posted : June 11, 2020
|Condition or disease|
|Head and Neck Cancer|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer|
|Actual Study Start Date :||April 23, 2019|
|Estimated Primary Completion Date :||April 23, 2022|
|Estimated Study Completion Date :||April 23, 2024|
|Radiotherapy Response Monitoring|
- Correlation of response to treatment between photoacoustic parameters and final radiological outcome. measures of outcome. [ Time Frame: 3 months ]The primary study endpoint will investigate changes of measured PA markers and compare these to radiological assessment of response of lymph node involvement to chemoradiation therapy for head and neck cancer. Changes in PA parameters will be made to a pre-treatment point over the course of treatment.
- Correlation between photoacoustic parameters and five-year overall survival. [ Time Frame: 5 years ]The secondary study endpoint will correlate changes of measured PA markers to five-year overall survival (OS) of the same patient cohort. The survival status and of the patient cohort will be tracked after the treatment for five years based on the patient information system and follow up surveys if necessary.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04428515
|Sunnybrook Health Sciences Centre||Recruiting|
|Toronto, Ontario, Canada, M4N3M5|
|Contact: Gregory J Czarnota, PhD, MD (416)480-6128 email@example.com|
|Principal Investigator:||Gregory J Czarnota, PhD, MD||Sunnybrook Health Sciences Centre|